Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Andrew Shorr, MD, MPH, MBA
Section Director, Pulmonary and Critical Care Medicine
Medstar Washington Hospital Center
Poster(s):
(P-109) A Phase I First-in-Human Study to Evaluate the Safety and Pharmacokinetic (PK) Properties of the Intravenously (IV) Administered OMN6, A Novel Antimicrobial Peptide Targeting
Acinetobacter baumannii
(AB), in Adults including Older Healthy Volunteers (HVs) Subjects
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-827) Epidemiology of Favorable vs. Unfavorable Outcomes in Hospitalized Patients with
S. aureus
Bacteremia in the US: A Multicenter Retrospective Cohort Study
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT